Mucosal Immune Response to Influenza Vaccination: Clinical Trials

1 trial for Mucosal Immune Response to Influenza Vaccination, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Mucosal Immune Response to Influenza Vaccination: new trials by email Literature Review of Mucosal Immune Response to Influenza Vaccination trials Research Report on Mucosal Immune Response to Influenza Vaccination

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
How Healthy Adults Respond to the Nasal Flu Vaccine
FluMist (Live Attenuated Influenza Vaccine) - Mucosal Immune Response to Influenza Vaccination
Phase 4Not yet recruitingUniversity of Alabama at Birmingham202026-12-012026-10-13

Narrower conditions

Influenza, Human (1)

Broader conditions

Infections (1)  ·  Orthomyxoviridae Infections (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Interventions

FluMist (1)

Sponsors

University of Alabama at Birmingham (1)

Countries

United States (1)

Top investigators

Kevin S Harrod, PhD (1)